Literature DB >> 20840182

Keloid explant culture: a model for keloid fibroblasts isolation and cultivation based on the biological differences of its specific regions.

Vanina Monique Tucci-Viegas1, Bernardo Hochman, Jerônimo P França, Lydia M Ferreira.   

Abstract

In vitro studies with keloid fibroblasts frequently present contradictory results. This may occur because keloids present distinct genotypic and phenotypic characteristics in its different regions, such as the peripheral region in relation to the central region. We suggest an explant model for keloid fibroblasts harvesting, standardising the initial processing of keloid samples to obtain fragments from different regions, considering its biological differences, for primary cell culture. The different keloid regions were delimited and fragments were obtained using a 3-mm diameter punch. To remove fragments from the periphery, the punch was placed in one longitudinal line extremity, respecting the lesion borders. For the central region, it was placed in the intersection of lines at the level of the largest longitudinal and transversal axes, the other fragments being removed centrifugally in relation to the first one. Primary fibroblast culture was carried out by explant. Flow cytometry analysis showed cell cycle differences between the groups, confirming its different origins and biological characteristics. In conclusion, our proposed model proved itself efficient for keloid fibroblast isolation from specific regions and cultivation. Its simplicity and ease of execution may turn it into an important tool for studying the characteristics of the different keloid-derived fibroblasts in culture.
© 2010 The Authors. Journal Compilation © 2010 Blackwell Publishing Ltd and Medicalhelplines.com Inc.

Mesh:

Year:  2010        PMID: 20840182      PMCID: PMC7951214          DOI: 10.1111/j.1742-481X.2010.00698.x

Source DB:  PubMed          Journal:  Int Wound J        ISSN: 1742-4801            Impact factor:   3.315


  40 in total

Review 1.  On the nature of hypertrophic scars and keloids: a review.

Authors:  F B Niessen; P H Spauwen; J Schalkwijk; M Kon
Journal:  Plast Reconstr Surg       Date:  1999-10       Impact factor: 4.730

2.  [The distrubution of cell cycle on fibrolasts derived from the pathlogical scars and analysis of Fas gene mutations in keloids using polymerse chain Reaction-based single-strand conformation polymorphism].

Authors:  F Lu; X Li
Journal:  Zhonghua Yi Xue Za Zhi       Date:  2000-09

Review 3.  The art and design of genetic screens: mammalian culture cells.

Authors:  Stefan Grimm
Journal:  Nat Rev Genet       Date:  2004-03       Impact factor: 53.242

Review 4.  The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation.

Authors:  P Angel; M Karin
Journal:  Biochim Biophys Acta       Date:  1991-12-10

5.  Efficacy of recombinant adenovirus-mediated double suicide gene therapy in human keloid fibroblasts.

Authors:  B Xu; Z Z Liu; G Y Zhu; J F Yang; J P Zhao; J C Wang; J L Cai
Journal:  Clin Exp Dermatol       Date:  2008-03-16       Impact factor: 3.470

Review 6.  Frontiers in mammalian cell culture.

Authors:  W L McKeehan; D Barnes; L Reid; E Stanbridge; H Murakami; G H Sato
Journal:  In Vitro Cell Dev Biol       Date:  1990-01

7.  Morphological and immunochemical differences between keloid and hypertrophic scar.

Authors:  H P Ehrlich; A Desmoulière; R F Diegelmann; I K Cohen; C C Compton; W L Garner; Y Kapanci; G Gabbiani
Journal:  Am J Pathol       Date:  1994-07       Impact factor: 4.307

8.  Inhibition of vascular endothelial growth factor expression in keloid fibroblasts by vector-mediated vascular endothelial growth factor shRNA: a therapeutic potential strategy for keloid.

Authors:  Guo-You Zhang; Cheng-Gang Yi; Xuan Li; Yan Zheng; Zhan-Guo Niu; Wei Xia; Zhou Meng; Cheng-Yue Meng; Shu-Zhong Guo
Journal:  Arch Dermatol Res       Date:  2008-02-01       Impact factor: 3.017

9.  Targeting of Sp1 transcription factor: a novel therapeutic approach for keloids, an in vitro analysis.

Authors:  A Mukhopadhyay; A Khoo; H H Cheong; S Y Chan; O Aalami; I J Lim; T T Phan
Journal:  Exp Dermatol       Date:  2007-12       Impact factor: 3.960

10.  Transforming growth factor-beta1-antisense modulates the expression of hepatocyte growth factor/scatter factor in keloid fibroblast cell culture.

Authors:  R Naim; A Naumann; J Barnes; A Sauter; K Hormann; D Merkel; W Aust; T Braun; M Bloching
Journal:  Aesthetic Plast Surg       Date:  2008-03       Impact factor: 2.326

View more
  8 in total

1.  Construction of a HOXA11-AS-Interact Ed Network in Keloid Fibroblasts Using Integrated Bioinformatic Analysis and in Vitro Validation.

Authors:  Qiang Wang; Wei Wang; Xiao-Jie Sun
Journal:  Front Genet       Date:  2022-03-31       Impact factor: 4.772

Review 2.  Regeneration of Dermis: Scarring and Cells Involved.

Authors:  Alexandra L Rippa; Ekaterina P Kalabusheva; Ekaterina A Vorotelyak
Journal:  Cells       Date:  2019-06-18       Impact factor: 6.600

Review 3.  The Keloid Disorder: Heterogeneity, Histopathology, Mechanisms and Models.

Authors:  Grace C Limandjaja; Frank B Niessen; Rik J Scheper; Susan Gibbs
Journal:  Front Cell Dev Biol       Date:  2020-05-26

4.  Identification of Differentially Methylated CpG Sites in Fibroblasts from Keloid Scars.

Authors:  Mansour A Alghamdi; Hilary J Wallace; Phillip E Melton; Eric K Moses; Andrew Stevenson; Laith N Al-Eitan; Suzanne Rea; Janine M Duke; Patricia L Danielsen; Cecilia M Prêle; Fiona M Wood; Mark W Fear
Journal:  Biomedicines       Date:  2020-06-28

5.  Long-term explant culture: an improved method for consistently harvesting homogeneous populations of keloid fibroblasts.

Authors:  Jing Li; Yuqing Zou; Song Wang; Shikai Guo; Zhishun Huang; Ran Huo
Journal:  Bioengineered       Date:  2022-01       Impact factor: 3.269

6.  Exosomes from human adipose-derived mesenchymal stem cells inhibit production of extracellular matrix in keloid fibroblasts via downregulating transforming growth factor-β2 and Notch-1 expression.

Authors:  Jing Li; Zhiyu Li; Song Wang; Jianhai Bi; Ran Huo
Journal:  Bioengineered       Date:  2022-04       Impact factor: 6.832

7.  Sorafenib exerts an anti-keloid activity by antagonizing TGF-β/Smad and MAPK/ERK signaling pathways.

Authors:  Wenbo Wang; Miao Qu; Lan Xu; Xiaoli Wu; Zhen Gao; Tingyu Gu; Wenjie Zhang; Xiaoyan Ding; Wei Liu; Yue-Lei Chen
Journal:  J Mol Med (Berl)       Date:  2016-06-24       Impact factor: 4.599

8.  Reconstructed human keloid models show heterogeneity within keloid scars.

Authors:  Grace C Limandjaja; Leonarda J van den Broek; Taco Waaijman; Melanie Breetveld; Stan Monstrey; Rik J Scheper; Frank B Niessen; Susan Gibbs
Journal:  Arch Dermatol Res       Date:  2018-10-28       Impact factor: 3.017

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.